Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Benzinga, KVUE, Devdiscourse and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 91d ago.
Quick answers
Why is "Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides" trending?
Because 7 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Why Is Capricor Therapeutics Stock Soaring Today? Benzinga · 94d ago
- Capricor: Q2 Earnings Snapshot KVUE · 94d ago
- Capricor's Stock Surge, Congo's Ebola Outbreak, and More in Health News Devdiscourse · 94d ago
- This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Benzinga · 94d ago
- Capricor soars on plan to amend DMD filing after adcomm setback Fierce Biotech · 94d ago
- Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes Reuters · 94d ago
- CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA Path Yahoo Finance · 94d ago
- Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Capricor Therapeutics, Inc. · 94d ago
Topics
Related trends
A Netflix Show Returns With A Second 100% Rotten Tomatoes Scored Season
North of North returns for a second season with another perfect 100% Rotten Tomatoes score.
Vikings-Bills Second Injury Report
The Bills ruled out WR Joshua Palmer and listed five players questionable for Monday night's game at the Vikings, while the Vikings ruled out WR Jauan Jennings.
Second California student hurt in deadly Spain train crash ID’d
Global coverage tracks the aftermath of a deadly Spanish high-speed rail crash, identifying victims and political fallout.
Western Digital Reports Quarterly Earnings Beat
Western Digital reports a quarterly earnings beat driven by AI demand, yet its stock faces volatile market reactions.
Doctors Reveal a 10-Second Balance Test to Assess Your Aging Health
Medical experts are highlighting simple physical assessments, including a 10-second balance test, as critical indicators of aging health and longevity.
Ukraine Reports Russian Order to Destroy Bridges Over Dnipro River
Ukraine reports a Russian order to destroy Dnipro River bridges amidst intensified strikes on Kyiv and worsening energy conditions.